Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
William Ruschhaupt, MD, is a Staff Physician in the Cleveland Clinic Department of Cardiovascular Medicine, Section of Vascular Medicine in the Heart and Vascular Institute. He is a specialist in treating peripheral vascular disease, arterial and venous disorders, leg ulcers and swollen leg related to cardiovascular disease. Dr. Ruschhaupt is a certified Diplomate of the American Board of Internal Medicine.
Following his undergraduate education at Muskingum College in Ohio, Dr. Ruschhaupt received his medical degree from the University of Pittsburgh School of Medicine. He completed his internship in internal medicine at the Dallas Veterans Administration at the University of Texas Southwestern in Dallas, Texas, and he took his residency at Cleveland Clinic. He earned his MBA from the Weatherhead School of Management at Case Western Reserve University in 1985.
Following his clinical training, Dr. Ruschhaupt served in the United States Army at the Tripler Army Medical Center in Hawaii as Chief of Emergency Medical Services and Chief of the Peripheral Vascular Disease Clinic. He completed his tour of duty in 1978 and was appointed as a Staff Physician in September 1978 and continues in that role.
Dr. Ruschhaupt's research interests have focused on coronary artery disease in patients with peripheral arterial disease, the prevention of deep vein thrombosis, the implementation of noninvasive diagnostic methods in treating peripheral vascular disease and the application of technologic advances in treating such disease. He has authored or co-authored a number of articles on his specialty interests and is author of "The Swollen Limb" in a medical textbook dedicated to peripheral vascular disease.
He is a member of the American College of Physicians-American Society of Internal Medicine, the Society of Vascular Medicine and the Academy of Medicine of Cleveland/Northern Ohio Medical Association.
In addition to his clinical duties, Dr. Ruschhaupt has served as Director for the Patient Financial Services Systems Development and Implementation Project. He has been Acting Chairman of the Department of Vascular Medicine as well as Section Head. Currently, he is Chairman of Global Patient Services and continues to assist as Physician Director of Institutional Relations and Development.
Dr. Ruschhaupt serves as a member of the Executive Council of Ronald McDonald House of Cleveland. He has served as a Director of the Regional Affiliate Board of Fifth Third Bank of Northeastern Ohio. He continues as a member of the Board of Directors of Swagelok in Solon, Ohio.
Adverse Effects Anticoagulants, Thrombophilia, Deep Vein Thrombosis, Leg Edema, Peripheral Artery Disease, Pulmonary Embolism, General Vascular Medicine, Vascular Diseases
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/9/2010, Dr. Ruschhaupt has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.